학술논문
ABCB1 Overexpression May Predispose Imatinib Treated CML Patients to the Development of Abl Kinase Domain Mutations, and May Be an Important Contributor to Acquired Resistance.
Document Type
Abstract
Author
Source
In Blood 16 November 2006 108(11):2144-2144
Subject
Language
ISSN
0006-4971